O'Shares Investment Advisers, LLC Bristol Myers Squibb CO Transaction History

O'Shares Investment Advisers, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $2.04 Million - $2.26 Million	-35,510 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$54.82 - $64.09 $3.8 Million - $4.44 Million	-69,238 Reduced 66.1%	35,510 $2.09 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $3,804 - $5,529	-82 Reduced 0.08%	104,748 $5.84 Million
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $338,072 - $440,985	6,870 Added 7.01%	104,830 $6.73 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $567,942 - $673,378	13,279 Added 15.68%	97,960 $4.97 Million

Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $220,735 - $244,084	4,947 Added 6.2%	84,681 $3.84 Million
Q1 2019 May 13, 2019	BUY	$45.12 - $53.8 $105,039 - $125,246	2,328 Added 3.01%	79,734 $3.8 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $3.77 Million - $4.89 Million	77,406 New	77,406 $4.02 Million

2,555

1.49B

25.9M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $85B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of O'Shares Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shares Investment Advisers, LLC with notifications on news.